EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights

Harsh Batra, Jason Aboudi Mouabbi, Qingqing Ding, Aysegul A Sahin, Maria Gabriela Raso iD

Cancers · 20.11.2023 · 15 (22) · 5491

DOI: 10.3390/cancers15225491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.11.2023. Verfasst von Harsh Batra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The second most common breast carcinoma, invasive lobular carcinoma, accounts for approximately 15% of tumors of breast origin. Its incidence has increased in recent times due in part to hormone replacement therapy and improvement in diagnostic modalities. Although believed to arise from the same cell type as their ductal counterpart, invasive lobular carcinomas (ILCs) are a distinct entity with different regulating genetic pathways, characteristic histologies, and different biology. The features most unique to lobular carcinomas include loss of E-Cadherin leading to discohesion and formation of a characteristic single file pattern on histology. Because most of these tumors exhibit estrogen receptor positivity and Her2 neu negativity, endocrine therapy has predominated to treat these tumors. However novel treatments like CDK4/6 inhibitors have shown importance and antibody drug conjugates may be instrumental considering newer categories of Her 2 Low breast tumors. In this narrative review, we explore multiple pathological aspects and translational features of this unique entity. In addition, due to advancement in technologies like spatial transcriptomics and other hi-plex technologies, we have tried to enlist upon the characteristics of the tumor microenvironment and the latest associated findings to better understand the new prospective therapeutic options in the current era of personalized treatment.

Schlagwörter

Stichwörter der Autor:innen

ILCbreast carcinomahormone receptor-positive breast cancersinvasive lobular carcinomatranslational medicinetumor microenvironment

Autor:innen und Institutionen

  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Maria Gabriela Raso

Zitieren

APA

Batra, H., Mouabbi, J. A., Ding, Q., Sahin, A. A., & Raso, M. G. (2023). Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. Cancers, 15(22), 5491. https://doi.org/10.3390/cancers15225491

Vancouver

Batra H, Mouabbi JA, Ding Q, Sahin AA, Raso MG. Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights. Cancers. 2023;15(22):5491. doi:10.3390/cancers15225491

BibTeX
@article{Batra2023,
  author = {Batra, Harsh and Mouabbi, Jason Aboudi and Ding, Qingqing and Sahin, Aysegul A and Raso, Maria Gabriela},
  title = {Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {22},
  pages = {5491},
  doi = {10.3390/cancers15225491}
}
Kostenlos starten →